Tokyo Tape
Sign in
← Ensuiko Sugar Refining

Half-year report · Q2

2112.TEDINET S100UNRS
Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥16.2bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥31.6bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥15.6bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥1.4bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥546m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥1.5bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥2.1bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.2bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥1.5bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥1.2bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥1.1bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.5bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥901m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.1bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥901m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥26.7bnat 2024-09-30Cons.Assets
Total assets¥27.5bnat 2024-03-31Cons.Assets
Total assets¥26.2bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥12.3bnat 2024-09-30Cons.Liabilities
Total liabilities¥13.8bnat 2024-03-31Cons.Liabilities
Net assets / equity¥14.4bnat 2024-09-30Cons.Net assets
Net assets / equity¥13.7bnat 2024-03-31Cons.Net assets
Net assets / equity¥12.5bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.8bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥2.3bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥2.8bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.3bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.2bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥2.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.1bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥434m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥372m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥227m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥76m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.8bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥38.532024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥53.952023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥33.012023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio53.9%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio49.8%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio47.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Otherother segmentsrevenue2024-04-01 → 2024-09-30¥67m
Otherother segmentsrevenue external2024-04-01 → 2024-09-30¥59m
Otherother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥8m
Otherother segmentssegment profit2024-04-01 → 2024-09-30¥39m
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥62m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥62m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥701m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue2024-04-01 → 2024-09-30¥838m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue external2024-04-01 → 2024-09-30¥799m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥39m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentsegment profit2024-04-01 → 2024-09-30¥186m
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue2024-04-01 → 2024-09-30¥15.3bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue external2024-04-01 → 2024-09-30¥15.3bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥14m
jpcrp040300-q2r_E00361-000Sugarreportable segmentsegment profit2024-04-01 → 2024-09-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥16.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥16.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥62m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥2.1bn
Otherother segmentsrevenue2023-04-01 → 2023-09-30¥67m
Otherother segmentsrevenue external2023-04-01 → 2023-09-30¥59m
Otherother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥8m
Otherother segmentssegment profit2023-04-01 → 2023-09-30¥37m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥59m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥59m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥621m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue2023-04-01 → 2023-09-30¥964m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue external2023-04-01 → 2023-09-30¥927m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥37m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentsegment profit2023-04-01 → 2023-09-30¥211m
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue2023-04-01 → 2023-09-30¥14.6bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue external2023-04-01 → 2023-09-30¥14.6bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥13m
jpcrp040300-q2r_E00361-000Sugarreportable segmentsegment profit2023-04-01 → 2023-09-30¥919m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥15.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥15.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥59m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 497
ItemContextValueUnit
Gross profitPrior1YTDDuration2066000000JPY
Gross profitCurrentYTDDuration3056000000JPY
Selling general and administrative expensesPrior1YTDDuration1519000000JPY
Selling general and administrative expensesCurrentYTDDuration1634000000JPY
Operating incomePrior1YTDDuration546000000JPY
Operating incomeCurrentYTDDuration1422000000JPY
Interest income noiPrior1YTDDuration17000000JPY
Interest income noiCurrentYTDDuration18000000JPY
Dividends income noiPrior1YTDDuration718000000JPY
Dividends income noiCurrentYTDDuration86000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration－JPY
Equity in earnings of affiliates noiCurrentYTDDuration11000000JPY
Other noiPrior1YTDDuration14000000JPY
Other noiCurrentYTDDuration18000000JPY
Non operating incomePrior1YTDDuration750000000JPY
Non operating incomeCurrentYTDDuration135000000JPY
Interest expenses noePrior1YTDDuration49000000JPY
Interest expenses noeCurrentYTDDuration43000000JPY
Equity in losses of affiliates noePrior1YTDDuration57000000JPY
Equity in losses of affiliates noeCurrentYTDDuration－JPY
Commission fee noePrior1YTDDuration3000000JPY
Commission fee noeCurrentYTDDuration2000000JPY
Other noePrior1YTDDuration0JPY
Other noeCurrentYTDDuration6000000JPY
Non operating expensesPrior1YTDDuration110000000JPY
Non operating expensesCurrentYTDDuration51000000JPY
Ordinary incomePrior1YTDDuration1186000000JPY
Ordinary incomeCurrentYTDDuration1505000000JPY
Gain on sales of investment securities eiPrior1YTDDuration1000000JPY
Gain on sales of investment securities eiCurrentYTDDuration21000000JPY
Extraordinary incomePrior1YTDDuration1000000JPY
Extraordinary incomeCurrentYTDDuration21000000JPY
Income before income taxesPrior1YTDDuration1188000000JPY
Income before income taxesCurrentYTDDuration1526000000JPY
Income taxes currentPrior1YTDDuration289000000JPY
Income taxes currentCurrentYTDDuration470000000JPY
Income taxes deferredPrior1YTDDuration-3000000JPY
Income taxes deferredCurrentYTDDuration0JPY
Income taxesPrior1YTDDuration286000000JPY
Income taxesCurrentYTDDuration471000000JPY
Profit lossPrior1YTDDuration901000000JPY
Profit lossCurrentYTDDuration1055000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration901000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration1055000000JPY
Profit lossPrior1YTDDuration901000000JPY
Profit lossCurrentYTDDuration1055000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration697000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-134000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration8000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration-14000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass